000			05618nam a22005777a 4500
001			sulb-eb0023010
003			BD-SySUS
005			20160413122331.0
007			cr nn 008mamaa
008			120828s2013 xxu| s |||| 0|eng d
020			_a9781607615484 _9978-1-60761-548-4
024	7		_a10.1007/978-1-60761-548-4 _2doi
050		4	_aRC648-665.2
072		7	_aMJG _2bicssc
072		7	_aMED027000 _2bisacsh
082	0	4	_a616.4 _223
245	1	0	_aEndocrine Hypertension _h[electronic resource] : _bUnderlying Mechanisms and Therapy / _cedited by Christian A Koch, George P Chrousos.
264		1	_aTotowa, NJ : _bHumana Press : _bImprint: Humana Press, _c2013.
300			_aXIV, 318 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aContemporary Endocrinology
505	0		_a Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics.-Syndromes of Mineralocorticoid Excess -- Hypertension in Patients with Cushing’s Syndrome -- Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity -- Congenital Adrenal Hyperplasia -- Adrenal Incidentalomas and Adrenal Hypertension -- Pheochromocytoma: Unmasking the Chameleon -- Hypertension in Growth hormone excess and deficiency -- Primary Hyperparathyroidism and Hypertension -- Hypertension, Vitamin D deficiency, and Calcium Metabolism -- Testosterone Deficiency or Male Hypogonadism -- Insulin Resistance and Hypertension -- Obesity-associated Hypertension.-Central mineralocorticoid receptors and cardiovascular disease.        Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics.-Syndromes of Mineralocorticoid Excess -- Hypertension in Patients with Cushing’s Syndrome -- Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity -- Congenital Adrenal Hyperplasia -- Adrenal Incidentalomas and Adrenal Hypertension -- Pheochromocytoma: Unmasking the Chameleon -- Hypertension in Growth hormone excess and deficiency -- Primary Hyperparathyroidism and Hypertension -- Hypertension, Vitamin D deficiency, and Calcium Metabolism -- Testosterone Deficiency or Male Hypogonadism -- Insulin Resistance and Hypertension -- Obesity-associated Hypertension.-Central mineralocorticoid receptors and cardiovascular disease.        Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics.-Syndromes of Mineralocorticoid Excess -- Hypertension in Patients with Cushing’s Syndrome -- Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity -- Congenital Adrenal Hyperplasia -- Adrenal Incidentalomas and Adrenal Hypertension -- Pheochromocytoma: Unmasking the Chameleon -- Hypertension in Growth hormone excess and deficiency -- Primary Hyperparathyroidism and Hypertension -- Hypertension, Vitamin D deficiency, and Calcium Metabolism -- Testosterone Deficiency or Male Hypogonadism -- Insulin Resistance and Hypertension -- Obesity-associated Hypertension.-Central mineralocorticoid receptors and cardiovascular disease.      .
520			_aThe prevalence of hypertension is almost three times as high as that of diabetes mellitus type 2, with both conditions being major risk factors for stroke, ischemic heart disease, cardiac arrhythmias, and heart failure.  The exact prevalence of hypertension related to hormonal derangements (endocrine hypertension) is not known but estimated to affect less than 15% of hypertensive patients.  Recent scientific discoveries have increased the understanding of the pathophysiologic mechanisms of hypertension.  In Endocrine Hypertension, a renowned panel of experts provides a comprehensive, state-of-the-art overview of this disorder, discussing when to assign an endocrine cause in one of  many conditions that may present with hypertension.   The first part of Endocrine Hypertension is dedicated to adrenal causes.  The second part of the volume concerns potential nonadrenal causes of hypertension, such as growth hormone excess or deficiency, primary hyperparathyroidism, vitamin D deficiency, testosterone deficiency, insulin resistance, obesity-associated hypertension, and the role of central mineralocorticoid receptors and cardiovascular disease. An important contribution to the literature, Endocrine Hypertension is an indispensable reference not only for endocrinologists, diabetologists, and adrenal investigators, but also for translational scientists and clinicians from cardiology, internal medicine, pediatrics, family medicine, geriatrics, urology, and reproductive medicine / gynecology.
650		0	_aMedicine.
650		0	_aObstetrics.
650		0	_aInternal medicine.
650		0	_aCardiology.
650		0	_aEndocrinology.
650		0	_aNephrology.
650		0	_aUrology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aEndocrinology.
650	2	4	_aInternal Medicine.
650	2	4	_aCardiology.
650	2	4	_aObstetrics/Perinatology.
650	2	4	_aNephrology.
650	2	4	_aUrology.
700	1		_aKoch, Christian A. _eeditor.
700	1		_aChrousos, George P. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781607615477
830		0	_aContemporary Endocrinology
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-60761-548-4
912			_aZDB-2-SME
942			_2Dewey Decimal Classification _ceBooks
999			_c45102 _d45102